All Shall Perish to Headline the ‘Night of The Living Shred Tour 2009′ with Born of Osiris

Oakland CA?s extreme metallers ALL SHALL PERISH are proud to announce the ?Night of The Living Shred Tour 2009′ with BORN OF OSIRIS, AFTER THE BURIAL, CALIBAN, and SUFFOKATE.

ALL SHALL PERISH shared their thoughts on the upcoming tour:

?This September will find ASP touring with a lot of familiar faces, and a few new ones. We are very excited to get a chance to co-headline with Born Of Osiris. I feel as a new and up-and-coming band, they are truly a class act filled with very talented musicians who know how to rock a crowd. Same goes for our support bands! After The Burial, Caliban, and Suffokate?! This is going to be a fun tour, be sure to come out to the shows and party with us!?

Current tour dates for the upcoming trek are listed below (more dates to follow):

September 4 –  Empire Theatre – Stockton, CA
September 5 –  LiskFest – Irvine, CA (w/ As I Lay Dying)
September 6 –  Red Electric – Las Vegas, NV
September 7 –  Gator?s – Farmington, NM
September 8 –  Marquis Theatre – Denver, CO
September 9  Bricktown Live – Oklahoma City, OK
September 11 –  Pop?s – St. Louis, MO
September 12 –  The Muse – Nashville, TN
September 13 –  The 7 Venue – Douglasville, GA
September 14 –  State Theatre – St. Petersburg (Tampa), FL
September 15 –  Edge – Jacksonville, FL
September 16 –  The Legion – Pensacola, FL
September 17 –  The High Ground – New Orleans, LA
September 18 –  Java Jazz – Houston, TX
September 19 –  The White Rabbit – San Antonio, TX
September 20 –  Ridglea Theater – Ft. Worth (Dallas), TX
September 22 –  The Attic – Dayton, OH
September 23 –  Peabody?s – Cleveland, OH
September 24 –  Crocodile Rock Café – Allentown, PA
September 25 –  Hangar 84 – Vineland, NJ
September 26 –  Jaxx – Springfield, VA
September 28 –  Rocko?s – Manchester, NH
September 29 –  Le Tulipe – Montreal, QC
September 30 –  The Opera House – Toronto, ON
October 2 –  Clearwater Theatre – Chicago, IL
October 3 –  Emerson Theatre – Indianapolis, IN

Comments are closed.